Skip to content
★ Sign in to follow
Shandong Xinhua Pharmaceutical Company Limited logo

Shandong Xinhua Pharmaceutical Company Limited Stock: price and insider trades · China

新华制药

CN·Mcap CN¥9.2BHealth Care

Shandong Xinhua Pharmaceutical Company Limited: what insiders have been doing

Shandong Xinhua Pharmaceutical Company Limited, classified in the Health Care sector, is a listed company based in Zhangdian District, People's Republic of China, founded in 1943. Its insiders report their share dealings to SSE / SZSE (CSRC). Shandong Xinhua Pharmaceutical Company Limited has had no insider filing for more than a year; the last one goes back to 29 July 2022.

Looking back to 2022, when coverage begins, insiders filed no purchases and 4 sales.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.

Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€255,367
4 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 14,969 of 26,911 companies
48.2
score / 100
Value
55
Quality
42
FCF yld4.5%
Earn yld3.1%
EV/EBITDA10.8x
ROE4.1%
Gross mgn19%
Net mgn3.3%
Debt/EBITDA1.5x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥13.26
Analyst consensus
1 analysts
·
CN¥9.00Target CN¥9.00(-32%)CN¥9.00
Income statement
RevenueCN¥8.8B
Gross profitCN¥1.6B19% margin
EBITDACN¥988.9M11% margin
Net incomeCN¥289.9M2.5% margin
Valuation
PER (trailing)42.8x
PER (forward)16.4x
P/Book1.8x
Beta-0.05
Balance sheet & cash
Market capCN¥9.2B
Total debtCN¥1.5B
Free Cash FlowCN¥418.1M
Debt / Equity26%
Profitability & ownership
ROE4.1%
ROA1.9%
% insiders49.8%
% institutions0.5%
Last declaration on 29 July 2022
Declarations4 total
  • ▼
    副总经理Executives
    774,587 CNY48SZSE
    36,850 shares100.0% of flowA股XSHESZSE:173000005729719460
  • ▼
    董秘Executives
    295,260 CNY30SZSE
    13,300 shares100.0% of flowA股XSHESZSE:173000005725071740
  • ▼
    高管Executives
    402,840 CNY34SZSE
    18,000 shares100.0% of flowA股XSHESZSE:173000005725071700
  • ▼
    高管Executives
    288,860 CNY34SZSE
    13,000 shares100.0% of flowA股XSHESZSE:173000005725071680

4 of 4 declarations

About Shandong Xinhua Pharmaceutical Company Limited

新华制药 is a pharmaceutical company based in China that specializes in the manufacturing of pharmaceutical products. It focuses on the development and production of generic drugs and innovative medications.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations